Based on our beneficial findings on inflammation and fibrosis in MCD diet and the CDAHFD-fed mice, we tested the antifibrotic effects of GPR84 antagonism in a third experimental model of liver fibrosis, based on repetitive intraperitoneal injections of CCl4, twice per week for a period of 8 weeks. The gene discussed is GPR84; the disease is Hepatic fibrosis.